Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease
By Elana Gotkine HealthDay Reporter
THURSDAY, May 22, 2025 -- Herpes simplex virus type 1 (HSV-1) is associated with an increased risk for Alzheimer disease (AD) based on real-world data from the United States, according to a study published online May 20 in BMJ Open.
Yunhao Liu, from Gilead Sciences Inc. in Foster City, California, and colleagues conducted a matched case-control study involving patients with AD aged 50 years and older diagnosed between 2006 and 2021 identified from the IQVIA PharMetrics Plus claims database to examine the association between HSV-1 and AD. Controls were matched with individuals with AD on age, sex, region, database entry year, and health care visit numbers in a 1:1 ratio (344,628 AD case-control pairs).
The researchers found that 0.44 and 0.24 percent of patients with AD and controls, respectively, had a history of HSV-1 diagnosis. There was an association for HSV-1 diagnosis with an increased risk for AD (adjusted odds ratio, 1.80). Compared with those who did not use antiherpetics, patients with HSV-1 who used antiherpetics were less likely to develop AD (adjusted hazard ratio, 0.83).
"These findings place an even greater emphasis on viewing the prevention of herpesviruses as a public health priority," the authors write. "Further research to determine whether suppression of neurotropic viruses can alter the natural history of AD and AD-related dementia is warranted based on the consistent observational studies."
Several authors disclosed ties to the pharmaceutical industry, including Gilead Sciences, which funded the study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...
Overwork Tied to Structural Changes in Brains of Health Care Workers
MONDAY, May 19, 2025 -- Overwork in health care workers is associated with structural brain changes, particularly in regions linked to cognition and emotion, according to a study...
Greater Sedentary Time Associated With Higher Risk for Alzheimer Disease
FRIDAY, May 16, 2025 -- Sedentary time is associated with an increased risk for Alzheimer disease (AD), according to a study published online May 13 in Alzheimer's &...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.